Navigation Links
Inovio Expands Synthetic Vaccine Intellectual Property License With University of Pennsylvania
Date:11/14/2012

BLUE BELL, Pa., Nov. 14, 2012 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) has expanded its existing license agreement with the University of Pennsylvania (UPenn), adding worldwide rights to technology and intellectual property for novel synthetic vaccines against cancer, infectious diseases and potential biodefense pathogens. These technologies were developed by UPenn Professor David B. Weiner and collaborators. Dr. Weiner is a pioneer in the field of DNA vaccines, and chairman of Inovio's scientific advisory board. All newly licensed products are in preclinical development.

In the new agreement, Inovio gains rights to synthetic vaccines to prevent and/or treat:

  • Intestinal infections – Clostridium difficile, or C. difficile, is an illness that most commonly affects older adults in hospitals or in long term care facilities, with symptoms ranging from diarrhea to life-threatening inflammation of the colon. It is responsible for more deaths than all other intestinal infections combined. Its incidence has doubled in the past 10 years.
  • Cancer – new cancer therapeutic vaccines targeting Wilms' tumor gene or WT1. WT1 is highly expressed in leukemia and various types of solid tumors, making it an appropriate anti-cancer target for multiple types of cancers.
  • Biodefense pathogens - includes the Ebola virus and the family of Filovirus such as Marburg - disease-causing agents that could potentially be used in bioterror attacks.

Dr. J. Joseph Kim, President and CEO, said, "Our synthetic vaccine technology offers the potential to prevent and/or treat a broad array of cancers and infectious diseases, and has achieved best-in-class immune responses in human studies. This new intellectual property from an eminent synthetic vaccine research laboratory at the University of Pennsylvania b
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Inovio Pharmaceuticals to Present at SPI 2012
4. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
5. Inovio Pharmaceuticals to Present at JMP Investor Conference
6. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
7. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
8. Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
10. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
11. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Calif. , July 10, 2014  Breg, ... and services, has launched the FreeRunner™ knee brace ... who suffer from patella mal-tracking return to active ... differently than other braces, providing support when patients ... normally when they don,t. Patellofemoral issues ...
(Date:7/10/2014)... Pa. , July 10, 2014 ... Moberg Research,s (Moberg) medical device manufacturing facility. Rep. ... Moberg,s advanced neurological monitors facilitate cutting-edge research in ... Rep. Kennedy and mental health advocate, Garen ... organization dedicated to fostering fundamental changes that will ...
(Date:7/10/2014)... , July 10, 2014   Ventana Medical Systems, ... announced it has entered into an agreement with Merck ... as EMD Serono in the United States ... collaborate with Merck KGaA,s biopharmaceutical division on the development ... undisclosed target using Ventana,s proprietary diagnostic assays. In alignment ...
Breaking Medicine Technology:Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2Representative Patrick Kennedy visits Moberg's medical device facility to discuss improvement in brain injury care 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3
... Data to be presented November 2 at the American Society of Nephrology ... ... Calif., Oct. 16 ,Exelixis, Inc. (Nasdaq: EXEL ) announced that a ... of reducing proteinuria,compared with placebo in patients with proteinuria associated with diabetic,nephropathy. ...
... Concentra, the largest,occupational health care provider with ... to educate America,s workforce about the flu, how ... The company expects to vaccinate,nearly 300,000 people across ... lost productivity. Concentra Medical Centers offers flu ...
Cached Medicine Technology:Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy 2Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy 3Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy 4Concentra Offers Flu Vaccines to Keep America Working 2
(Date:7/12/2014)... (PRWEB) July 12, 2014 “After my mom’s stroke, ... had a stroke and loss the use of his left side. ... design a way to help people like them enjoy eating again,” ... a prototype for the PATRICIA CAROL HALL PLATE (P C H ... offers a more ergonomic way to eat for individuals who suffer ...
(Date:7/12/2014)... July 12, 2014 Wright & Schulte LLC ... Orthopedics , Inc., a subsidiary of Johnson & Johnson, on ... chronic pain after receiving a metal-on-metal DePuy Pinnacle hip replacement ... remove the artificial hip implant. The DePuy hip lawsuit was ... District of Texas (Case No. 3:14-cv-2427) where DePuy Pinnacle ...
(Date:7/12/2014)... 2014 Dubai is buzzing with the ... heading to the UAE. The National Basketball Association’s ... in the UAE from 28-31 October to lead the ... diabetes awareness. The event is being organized by Maven ... management company based in Dubai. The announcement was made ...
(Date:7/12/2014)... 12, 2014 Floor-grade instrument ... 4.1 out of 5. This above-average score represents ... underpinning buyer negotiation power over the three years ... Son, “during the period, surging demand for healthcare ... with new product development, have placed upward pressure ...
(Date:7/11/2014)... Recently, DressyQuinceanera.com, a well-known wedding dress manufacturer and retailer, ... its online category. Furthermore, the firm has announced that ... up to 62% off. , The brand new Quinceanera ... of quality and style. All items in the new ... for the company’s other items: lace evening dresses, short ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 5Health News:Los Angeles Basketball Legend Headed to Dubai 2Health News:Los Angeles Basketball Legend Headed to Dubai 3Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:DressyQuinceanera.com: Beautiful Quinceanera Dama Dresses At Low Prices 2
... Nov. 8 Synova Healthcare Group,Inc. (OTC Bulletin Board: ... its Today(R) Sponge non-hormonal contraceptive,product in Hong Kong and ... Hong Kong. This represents an important milestone for the,Company, ... made the Today(R) Sponge,available to women outside North America. ...
... Nov. 8, 2007 An Israeli-Jordanian-U.S. cooperative project aimed ... neighboring southern cities of Aqaba in Jordan and Eilat ... Hebrew University of Jerusalem together with scientists from the ... Research Institute of Reno, Nevada, in the US. ...
... determined how cardiac cells die just as emergency treatments restore blood ... puzzled doctors who are able to relieve pain in patients suffering ... renewed rush of blood. , The discovery may lead to ... the stoppage of blood flow and resulting loss of oxygen to ...
... , The topic of cancer prevention is covered ... with apparently conflicting information and complex scientific research that ... The American Association for Cancer Research (AACR) and Susan ... communication between the scientific research community and journalists who ...
... New Law and New Regulations Could Hold the Key to ... Reducing Rising Skin Cancer Rates, NEW YORK, ... of skin cancer will be diagnosed in the United States in,2007. While ... stress that prevention is still the best,medicine. In fact, dermatologists are hopeful ...
... NEW YORK, Nov. 8 The changing of the ... to health clubs for a,healthy dose of indoor exercise. ... beneficial activities a person can do to improve one,s ... the hidden dangers of,exercise -- bothersome skin conditions that ...
Cached Medicine News:Health News:Today(R) Sponge to be Distributed in Hong Kong and Macau 2Health News:Today(R) Sponge to be Distributed in Hong Kong and Macau 3Health News:'Beam of Light' is ray of hope for Israeli-Jordanian cooperation 2Health News:Mitochondria send death signal to cardiac cells, study shows 2Health News:Mitochondria send death signal to cardiac cells, study shows 3Health News:Skin Cancer Prevention Update: 2Health News:Skin Cancer Prevention Update: 3Health News:Skin Cancer Prevention Update: 4Health News:Skin Cancer Prevention Update: 5Health News:Dermatologists Warn Fitness Enthusiasts: Don't Let Exercise-Related Skin Problems Outweigh the Benefits of Physical Activity 2Health News:Dermatologists Warn Fitness Enthusiasts: Don't Let Exercise-Related Skin Problems Outweigh the Benefits of Physical Activity 3Health News:Dermatologists Warn Fitness Enthusiasts: Don't Let Exercise-Related Skin Problems Outweigh the Benefits of Physical Activity 4Health News:Dermatologists Warn Fitness Enthusiasts: Don't Let Exercise-Related Skin Problems Outweigh the Benefits of Physical Activity 5
... Combining exceptional new features ... XLTEKs latest innovation, the ... biphasic intracranial stimulation up ... 300 volts and transcranial ...
... high-volume analyzer that builds upon the field-proven ... and the latest Olympus technological advances. The ... with up to 147 on-board chemistries and ... Choose from Olympus 122 test menu, including ...
... e is designed for the ... laboratories and hospitals. Automate and consolidate ... reliability and Olympus 122 test menu, ... specific proteins, esoteric chemistries and tests ...
... is intended for the quantitative determination of Erythropoietin ... for in vitro diagnostic use, as an aid ... the advent of the administration of recombinant erythropoietin ... cell mass, an erythropoietin assay may be used ...
Medicine Products: